2022 (v1)
Publication
No description
Uploaded on: February 11, 2024
-
-
2020 (v1)Publication
Thyroid-associated ophthalmopathy (TAO), also known as thyroid eye disease, is the most common ocular manifestation in patients with Graves' disease. High-dose glucocorticoids and other immunosuppressive agents represent the most adopted treatment options for TAO; however, none of them has given optimal results in terms of clinical efficacy and...
Uploaded on: April 14, 2023